Conference themes
With race to market for the first allogeneic and solid tumor targeting cell immunotherapy well and truly on, the explosive excitement in Gamma Delta T Therapies continues to increase, as we begin to see the early clinical data read out on safety and efficacy.
The annual Gamma Delta T Therapies Summit returns online as a 3 day virtual event gathering the world’s leaders harnessing GDT cells to bring to market the first effective, allogeneic cell therapy for solid tumors.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/746170-0?pid=4832
Speakers: Lawrence Lamb, Chief Scientific Officer, IN8Bio, Mihriban Tuna, Chief Scientific Officer, Adaptate Biotherapeutics and more
Enquiries and Registration:
https://go.evvnt.com/746170-1?pid=4832
Mr. Gamma Delta T Therapies Team
CategoriesClinical Research, General Medicine
